Literature DB >> 18564905

Epidemiology of sepsis in the Valencian Community (Spain), 1995-2004.

Juan Carlos Andreu Ballester1, Ferran Ballester, Antonio González Sánchez, Amadeo Almela Quilis, Enrique Colomer Rubio, Carlos Peñarroja Otero.   

Abstract

OBJECTIVE: To study the incidence of sepsis in the Valencian Community (Spain) during a period of 10 years (1995-2004).
METHODS: We downloaded data on discharge diagnoses of septicemia in all 26 public hospitals in the Valencian Community during the 10-year study period, as well as the additional discharge diagnoses of each patient.
RESULTS: We identified 33,767 cases of sepsis during the study period. The age-standardized incidence rates among men increased from 64.11 (95% confidence interval [CI], 60.37-67.85) cases per 100,000 population in 1995 to 114.02 (95% CI, 109.02-118.50) cases per 100,000 population in 2004 (P < .001), and those among women increased from 45.08 (95% CI, 42.01-48.15) cases per 100,000 population in 1995 to 83.62 (95% CI, 79.85-87.39) cases per 100,000 population in 2004 (P < .001). Gram-negative bacteria were the most frequently involved microorganisms (in 21.4% of cases), and there was a significant increase in the number of sepsis cases caused by these organisms from 1999 onward. The mortality rate was approximately 42.5% among patients hospitalized for sepsis, and mortality was associated with organ failure. In addition, mortality was associated with the microorganism responsible not being known, with infection due to fungi, and with polymicrobial sepsis.
CONCLUSIONS: The rates of hospitalization both for sepsis overall and for severe sepsis in the Valencian Community (Spain) are lower than those in other countries but are increasing, by 5% each year. The increase in the number of cases in which gram-negative bacteria are the cause of sepsis is notable.

Entities:  

Mesh:

Year:  2008        PMID: 18564905     DOI: 10.1086/589583

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  17 in total

Review 1.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

Review 2.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Manu Shankar-Hari; Gary S Phillips; Mitchell L Levy; Christopher W Seymour; Vincent X Liu; Clifford S Deutschman; Derek C Angus; Gordon D Rubenfeld; Mervyn Singer
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  Association of γδ T cells with disease severity and mortality in septic patients.

Authors:  Juan C Andreu-Ballester; Constantino Tormo-Calandín; Carlos Garcia-Ballesteros; J Pérez-Griera; Victoria Amigó; Amadeo Almela-Quilis; Juan Ruiz del Castillo; Carlos Peñarroja-Otero; Ferran Ballester
Journal:  Clin Vaccine Immunol       Date:  2013-03-20

4.  Raftlin: a new biomarker in human sepsis.

Authors:  Wonhwa Lee; Hayoung Yoo; Sae-Kwang Ku; Shin-Woo Kim; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

5.  Trends in hospitalizations of patients with sepsis and factors associated with inpatient mortality in the Region of Madrid, 2003–2011.

Authors:  O H Ayala-Ramírez; M F Domínguez-Berjón; M D Esteban-Vasallo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03       Impact factor: 3.267

6.  Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients.

Authors:  André M Japiassú; Rodrigo T Amâncio; Emerson C Mesquita; Denise M Medeiros; Helena B Bernal; Estevão P Nunes; Paula M Luz; Beatriz Grinsztejn; Fernando A Bozza
Journal:  Crit Care       Date:  2010-08-10       Impact factor: 9.097

7.  Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study.

Authors: 
Journal:  Intensive Care Med       Date:  2016-09-29       Impact factor: 17.440

8.  Effects of vitamin b6 therapy for sepsis patients with linezolid-associated cytopenias: a retrospective study.

Authors:  Jie Deng; Long-Xiang Su; Zhi-Xin Liang; Li-Ling Liang; Peng Yan; Yan-Hong Jia; Xin-Gang Zhang; Dan Feng; Li-Xin Xie
Journal:  Curr Ther Res Clin Exp       Date:  2013-06

9.  Epidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006-2011).

Authors:  Carmen Bouza; Teresa López-Cuadrado; Zuleika Saz-Parkinson; José María Amate-Blanco
Journal:  BMC Infect Dis       Date:  2014-12-21       Impact factor: 3.090

10.  The innate immune response in HIV/AIDS septic shock patients: a comparative study.

Authors:  Rodrigo T Amancio; Andre M Japiassu; Rachel N Gomes; Emersom C Mesquita; Edson F Assis; Denise M Medeiros; Beatriz Grinsztejn; Patrícia T Bozza; Hugo C Castro-Faria Neto; Fernando A Bozza
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.